Skip to main content
. 2023 Feb 1;2023:1978536. doi: 10.1155/2023/1978536

(b).

Died (n, %)
57 (26.4)
Hospital discharge (n, %)
159 (73.6)
p value
Complications
Risk of dysphagia, yes (n, %) 26 (38.8) 41 (61.2) <0.001
Raised ICP, yes (n, %) 21 (75.0) 7 (25.0) <0.001
Malignant MCA, yes (n, %) 9 (90.0) 1 (10.0) <0.001
Hydrocephalus, yes (n, %) 10 (55.4) 8 (44.4) 0.023
Depression, yes (n, %) 0 (0.0) 7 (100.0) 0.125
Haemorrhagic transformation, yes (n, %) 4 (66.7) 2 (33.3) 0.023
Aspiration pneumonia, yes (n, %) 29 (59.2) 20 (40.8) <0.001
Acute kidney injury, yes (n, %) 12 (38.7) 19 (61.2) 0.052
Urinary tract infection, yes (n, %) 4 (14.3) 24 (85.7) 0.183
PE/DVT, yes (n, %) 1 (50.3) 1 (50.0) 0.443
Myocardial infarction, yes (n, %) 2 (100.0) 0 (0.0) 0.061
Hyponatremia, yes (n, %) 5 (23.8) 16 (76.2) 0.984
Sepsis, yes (n, %) 10 (52.6) 9 (47.4) 0.004
Miscellaneous, yes (n, %) 9 (60.0) 6 (40.0) 0.001

Abbreviations: CVS: cardiovascular disease; ICP: intracranial pressure; MCA: middle cerebral artery; PE/DVT: pulmonary embolism/deep vein thrombosis. Miscellaneous complications included persistent hyperglycemia/hypertension, hyperkalemia/hypokalemia, hypernatremia, anaemia, obstructive sleep apnoea, pulmonary oedema, and HELLP syndrome. Fisher exact test.